文献速递甲状腺与颈部外科围术期管理与 ERAS

甲状旁腺自发荧光:全甲状腺切除术后低钙血症的条件性成本效益工具

Parathyroid autofluorescence: A conditionally cost-effective tool to reduce postoperative hypocalcemia after total thyroidectomy.
PubMed 文献 · Surgery · 2025-11-14

该系统综述与成本效益分析纳入10项随机对照试验共1878例患者,发现基于成像的自发荧光与降低误切甲状旁腺(OR 0.42)和术后低钙血症(OR 0.59)相关;在高手术量中心长期使用可节省成本,成本效益具条件性。

要点

  • 自发荧光可减少误切甲状旁腺(OR 0.42)和术后低钙血症(OR 0.59)。
  • 高手术量中心(≥200例/年)使用10年可节省成本。
  • 中等手术量中心(≥50例/年)使用10年也可节省成本。

核心结论

  • 基于成像的自发荧光与降低甲状腺切除术后低钙血症风险相关,并在延长设备使用期后具有条件性成本节约。

研究设计与样本

  • 通过系统综述纳入10项随机对照试验(2019-2024年),汇总队列1878例患者(77%女性,平均年龄50岁)。
  • 采用逆方差法进行固定和随机效应模型荟萃分析,并基于设备固定前期成本和经常性成本进行成本效益分析。

主要发现

  • 自发荧光与减少误切甲状旁腺相关(OR 0.42,95%CI 0.19-0.92)。
  • 自发荧光与减少术后低钙血症相关(OR 0.59,95%CI 0.43-0.81)。
  • 计算显示无自发荧光时17%的病例发生暂时性低钙血症,有自发荧光时为11%。

关键数值与推荐

  • 高手术量中心(≥200例甲状腺切除术/年)设备购买增量成本1年时为+36,458美元,10年时节省382,413美元。
  • 中等手术量中心(≥50例甲状腺切除术/年)增量成本1年时为+71,365美元,10年时节省33,353美元。

临床怎么用

  • 在高手术量中心可考虑采用基于成像的自发荧光技术以降低术后低钙血症并实现长期成本节约。
  • 中等手术量中心需评估设备使用周期,长期使用可能具有成本效益。

局限性

  • 成本效益分析基于术后低钙血症率作为效果和过夜住院可能性的替代指标。
  • 研究仅纳入英文文献,且排除总事件数<5或缺失24小时术后低钙血症和病理甲状旁腺数量的研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative hypocalcemia due to parathyroid removal/injury remains a major source of morbidity after thyroidectomy. Technologies using autofluorescence for parathyroid identification allow for parathyroid preservation. We aimed to determine if imaging-based autofluorescence was associated with decreased postoperative hypocalcemia and cost-effective. METHODS: Randomized controlled trials examining patients undergoing total/completion thyroidectomy with versus without imaging-based autofluorescence were identified through a systematic review. Exclusion criteria included non-English language, total events <5, or missing 24-hour postoperative hypocalcemia and number of parathyroids on pathology. Meta-analysis was performed using inverse variance method for fixed and random effects models. For cost-effectiveness analysis, fixed upfront device plus recurring costs for the autofluorescence group were summed. Postoperative hypocalcemia rates were used as a proxy for effectiveness and overnight hospitalization likelihood. RESULTS: Ten studies (2019-2024) with a pooled cohort of 1,878 patients (77% female, mean age 50 years) were included. Autofluorescence was associated with reduced inadvertent parathyroidectomy (odds ratio 0.42, 95% confidence interval 0.19-0.92) and postoperative hypocalcemia (odds ratio 0.59, 95% confidence interval 0.43-0.81). We calculated 17% of cases without and 11% with autofluorescence would have transient hypocalcemia. At high-volume centers (≥200 thyroidectomies/year), the incremental cost of device purchase at 1 year is +$36,458; at 10 years it saves -$382,413. In moderate-volume centers (≥50 thyroidectomies/year) the incremental costs were +$71,365 at 1 year and a savings of -$33,353 at 10 years. CONCLUSIONS: Imaging-based autofluorescence was associated with reduced risk of postoperative hypocalcemia after thyroidectomy and was conditionally cost-saving over extended device usage periods. Future studies examining the cost-effectiveness of other applications are warranted.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Fergus KB, Conroy PC, Thiesmeyer J, et al. Parathyroid autofluorescence: A conditionally cost-effective tool to reduce postoperative hypocalcemia after total thyroidectomy. Surgery. 2025. PMID: 41237690. doi:10.1016/j.surg.2025.109853

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。